Venous thromboembolism (VTE): Nursing process (ADPIE)

Last updated: October 29, 2025

Venous thromboembolism (VTE): Nursing process (ADPIE)

Watch later

Watch later

Infection prevention and control - Precautions and personal protective equipment (PPE): Nursing skills
Urinary tract infections (UTIs): Nursing process (ADPIE)
Modes of infectious disease transmission
Epstein-Barr virus (Infectious mononucleosis)
Pneumonia
Wound healing
Palliative and hospice care: Nursing
Postoperative care: Nursing
Biology of cancer: Nursing
Biliary atresia: Nursing
Cholecystitis: Nursing
Cholelithiasis: Nursing
Colorectal cancer: Nursing
Diarrhea: Nursing
Diverticular disease: Nursing
Esophageal cancer: Nursing
Gastric cancer: Nursing
Hepatitis: Nursing
Inflammatory bowel disease - Crohn disease and ulcerative colitis: Nursing
Intestinal obstruction: Nursing
Irritable bowel syndrome (IBS): Nursing
Jaundice: Nursing
Laryngeal cancer: Nursing
Liver cancer: Nursing
Pancreatic cancer: Nursing
Esophageal atresia and tracheoesophageal fistula: Nursing
Geriatric considerations - Gastrointestinal: Nursing
Hirschsprung disease: Nursing
Hyperemesis gravidarum: Nursing
Necrotizing enterocolitis: Nursing
Omphalocele and gastroschisis: Nursing
Appendicitis: Nursing process (ADPIE)
Celiac disease: Nursing process (ADPIE)
Cirrhosis: Nursing process (ADPIE)
Gastroesophageal reflux disease (GERD): Nursing process (ADPIE)
Hiatal hernia: Nursing process (ADPIE)
Pancreatitis: Nursing process (ADPIE)
Peptic ulcer disease (PUD): Nursing process (ADPIE)
Antacids: Nursing pharmacology
Antidiarrheals: Nursing pharmacology
Antiemetics: Nursing pharmacology
Antispasmodics (GI): Nursing pharmacology
Gallstone-dissolving agents: Nursing pharmacology
Gastric mucosal protective agents: Nursing pharmacology
Histamine H2 antagonists: Nursing pharmacology
Laxatives: Nursing pharmacology
Medications for hepatic encephalopathy: Nursing pharmacology
Pancreatic enzyme replacements: Nursing pharmacology
Proton pump inhibitors (PPIs): Nursing pharmacology
Treatment for Helicobacter pylori: Nursing pharmacology
Weight loss medications: Nursing pharmacology
Bladder tumors: Nursing
Chronic kidney disease (CKD): Nursing
Dialysis care: Nursing
Epididymitis: Nursing
Glomerulonephritis: Nursing
Nephrotic syndrome: Nursing
Polycystic kidney disease (PKD): Nursing
Prostate cancer: Nursing
Pyelonephritis: Nursing
Renal and urinary calculi: Nursing
Renal cancer: Nursing
Testicular cancer: Nursing
Urinary retention: Nursing
Bladder exstrophy: Nursing
Circumcision: Nursing
Cryptorchidism: Nursing
Enuresis: Nursing
Geriatric considerations - Urinary: Nursing
Hypospadias and epispadias: Nursing
Acute kidney injury (AKI): Nursing process (ADPIE)
Benign prostatic hyperplasia (BPH): Nursing process (ADPIE)
Urinary incontinence - Stress: Nursing process (ADPIE)
Antispasmodics (GU): Nursing pharmacology
Cholinergic therapy (GU): Nursing pharmacology
Diuretics - Osmotic and carbonic anhydrase inhibitors: Nursing pharmacology
Diuretics - Thiazide, thiazide-like, loop, and potassium-sparing diuretics: Nursing pharmacology
Anemia - Aplastic: Nursing
Anemia - Iron-deficiency: Nursing
Anemia - Macrocytic: Nursing
Arterial blood gas (ABG) - Overview: Nursing
Arterial blood gas (ABG) - Metabolic acidosis: Nursing
Arterial blood gas (ABG) - Metabolic alkalosis: Nursing
Arterial blood gas (ABG) - Respiratory acidosis: Nursing
Arterial blood gas (ABG) - Respiratory alkalosis: Nursing
Blood cultures: Nursing
Cardiac biomarkers - Creatine kinase (CK): Nursing
Cardiac biomarkers - Troponin: Nursing
Coagulation studies - Partial thromboplastin time (PTT): Nursing
Complete blood count (CBC) - Hemoglobin and hematocrit: Nursing
Complete blood count (CBC) - Platelets: Nursing
Complete blood count (CBC) - Red blood cells (RBC): Nursing
Complete blood count (CBC) - White blood cells (WBC) and differential: Nursing
Complete metabolic panel (CMP) - Blood urea nitrogen (BUN) and creatinine (Cr): Nursing
Complete metabolic panel (CMP) - Chloride: Nursing
Complete metabolic panel (CMP) - Estimated glomerular filtration rate (eGFR): Nursing
Complete metabolic panel (CMP) - Glucose: Nursing
Complete metabolic panel (CMP) - Liver function tests (LFT): Nursing
Complete metabolic panel (CMP) - Potassium: Nursing
Complete metabolic panel (CMP) - Sodium: Nursing
Complete metabolic panel (CMP) - Total protein: Nursing
Disseminated intravascular coagulation (DIC): Nursing
Multiple myeloma: Nursing
Neutropenia: Nursing
Polycythemia: Nursing
Thalassemia: Nursing
Thrombocytopenia: Nursing
Leukemia: Nursing process (ADPIE)
Anticoagulants - Direct thrombin and factor Xa inhibitors: Nursing pharmacology
Anticoagulants - Heparin: Nursing pharmacology
Anticoagulants - Warfarin: Nursing pharmacology
Antihyperlipidemics - Bile acid sequestrants and cholesterol absorption inhibitors: Nursing pharmacology
Antihyperlipidemics - Fibrates: Nursing pharmacology
Antihyperlipidemics - Miscellaneous: Nursing pharmacology
Antihyperlipidemics - Statins: Nursing pharmacology
Antiplatelet agents: Nursing pharmacology
Blood products: Nursing pharmacology
Hematopoietic growth factors: Nursing pharmacology
Hemostatics: Nursing pharmacology
Iron preparations: Nursing pharmacology
Thrombolytics: Nursing pharmacology
Autoimmunity: Nursing
Human immunodeficiency virus (HIV) and acquired immunodeficiency syndrome (AIDS): Nursing
Hypersensitivity reactions - Type I: Nursing
Hypersensitivity reactions - Type II: Nursing
Hypersensitivity reactions - Type III: Nursing
Hypersensitivity reactions - Type IV: Nursing
Immune response - Adaptive: Nursing
Immune response - Innate: Nursing
Immunodeficiency disorders - Primary: Nursing
Immunodeficiency disorders - Secondary: Nursing
Inflammatory process: Nursing
Scleroderma: Nursing
Shock - Anaphylactic: Nursing
Sjögren syndrome: Nursing
Systemic lupus erythematosus (SLE): Nursing
Toxic shock syndrome (TSS): Nursing
Erythema infectiosum (Fifth disease): Nursing
Fever: Nursing
Infectious mononucleosis: Nursing
Mumps (Parotitis): Nursing
Neonatal sepsis: Nursing
Pertussis: Nursing
Poliomyelitis: Nursing
Postpartum infections: Nursing
Roseola (Exanthem subitum): Nursing
Rubella (German measles): Nursing
Rubeola (Measles): Nursing
Smallpox: Nursing
Zika virus: Nursing
Anaphylaxis: Nursing process (ADPIE)
Lyme disease: Nursing process (ADPIE)
Rheumatoid arthritis (RA): Nursing process (ADPIE)
Antirejection immunosuppressants: Nursing pharmacology
Biologic agents: Nursing pharmacology
Disease-modifying therapy for multiple sclerosis: Nursing pharmacology
Immunoglobulins: Nursing pharmacology
Immunomodulators: Nursing pharmacology
Immunosuppressants for autoimmune diseases: Nursing pharmacology
Non-biologic disease-modifying antirheumatic drug (DMARD) therapy: Nursing pharmacology
Vaccines: Nursing pharmacology
Acne: Nursing
Animal and snake bites: Nursing
Burn injury: Nursing
Cutaneous fungal infections: Nursing
Erysipelas and cellulitis: Nursing
Folliculitis, carbuncles, and furuncles: Nursing
Herpes simplex virus (HSV): Nursing
Herpes zoster: Nursing
Impetigo: Nursing
Insect stings and bites: Nursing
Pediculosis and scabies: Nursing
Psoriasis: Nursing
Rocky Mountain spotted fever (RMSF): Nursing
Skin cancer - Basal cell carcinoma, squamous cell carcinoma, and melanoma: Nursing
Urticaria: Nursing
Geriatric considerations - Integumentary: Nursing
Atopic dermatitis: Nursing process (ADPIE)
Frostbite: Nursing process (ADPIE)
Methicillin-resistant Staphylococcus aureus (MRSA): Nursing process (ADPIE)
Pressure injury: Nursing process (ADPIE)
Antibiotics - Topical: Nursing pharmacology
Antifungals - Topical: Nursing pharmacology
Corticosteroids - Topical: Nursing pharmacology
Debridement agents: Nursing pharmacology
Keratolytics: Nursing pharmacology
Medications for acne vulgaris: Nursing pharmacology
Osteoarthritis: Nursing
Osteomyelitis: Nursing
Osteoporosis: Nursing
Hip fractures: Nursing
Developmental dysplasia of the hip: Nursing
Acute compartment syndrome: Nursing process (ADPIE)
Fractures: Nursing process (ADPIE)
Gout: Nursing process (ADPIE)
Musculoskeletal injuries: Nursing process (ADPIE)
Buerger disease: Nursing
Raynaud phenomenon: Nursing
Peripheral arterial disease (PAD): Nursing process (ADPIE)
Peripheral venous disease (PVD): Nursing process (ADPIE)
Atelectasis: Nursing
Geriatric considerations - Respiratory: Nursing
Venous thromboembolism (VTE): Nursing process (ADPIE)
Asthma: Nursing process (ADPIE)
Bacterial pneumonia: Nursing process (ADPIE)
Bronchiolitis and respiratory syncytial virus (RSV): Nursing process (ADPIE)
Carbon monoxide poisoning: Nursing process (ADPIE)
Chronic obstructive pulmonary disease (COPD): Nursing process (ADPIE)
Epiglottitis: Nursing process (ADPIE)
Foreign body aspiration and upper airway obstruction: Nursing process (ADPIE)
Laryngotracheobronchitis (LTB) and croup: Nursing process (ADPIE)
Smoke inhalation injury: Nursing process (ADPIE)
Papulosquamous and inflammatory skin disorders: Pathology review

Notes

VENOUS THROMBOEMBOLISM (VTE)

KEY POINTS
NOTES
PATIENT REPORT
  • 34-year-old woman
  • Shortness of breath, chest pain, blood-tinged sputum
  • Delivered healthy, full-term infant via C-section 1 week ago
  • No other significant medical history

PATHOPHYSIOLOGY
  • Pulmonary embolism
    • Embolus lodges in pulmonary artery
    • Pulmonary circulation obstructed
  • Deep vein thrombosis (DVT)
    • Clot forms in a large vein
  • Venous thromboembolism
    • Blood clot forms in a vein
  • Risk factors
    • Virchow triad
  • Signs and symptoms (PE)
    • Depend on size and location of pulmonary artery blockage
    • Dyspnea
    • Cough
    • Tachypnea
    • Chest pain
    • Disorientation
    • Anxious
    • Apprehension or impending doom
    • Hemoptysis
  • Complications (PE)
    • Pulmonary hypertension
    • Right ventricular failure
    • Shock
    • Death

DIAGNOSIS AND TREATMENT
  • Diagnosis
    • CT
    • V/Q scan
    • Laboratory tests
  • Treatment
    • Small
      • Resolve on own
    • Large
      • Fibrinolytics
      • Anticoagulants
      • Embolectomy
      • IVC filter

ASSESSMENT
  • Short of breath, pain with breathing
  • Anxious
  • Dyspneic with conversation
  • Telemetry: sinus tachycardia
  • Heart rate: 110
  • Respiratory rate: 30, shallow
  • Productive cough with blood-tinged sputum
  • Crackles
  • Blood pressure: 95/72 mmHg
  • Temperature: 98.6 F (37.0 C)
  • Pain: 6/10
  • Oxygen saturation: 90% room air
  • Unilateral calf swelling and warmth
  • Hemoglobin: 12.5 mg/dL (125 g/L)
  • Hematocrit: 40%
  • Red blood cells: 5.0 million/mm3 (5.0 x1012/L)
  • White blood cells: 15,000 cells/mm(15 x 109/L)
  • Prothrombin time: 10 seconds
  • Activated partial thromboplastin time: 30 seconds
  • D-dimer: 2300 ng/dL (23 mg/L)
  • Troponin: 0.2 ng/dL (2 μg/L)
  • pH: 7.49
  • PaCO2: 30 mmHg (4.0 kPa)
  • HCO3-: 20 mEq/L (20 mmol/L)

NURSING DIAGNOSES
  • Impaired gas exchange related to decreased lung perfusion
  • Ineffective breathing pattern related to anxiety and dyspnea
  • Acute pain related to verbalization of pain
  • Anxiety related to verbalization and situational crisis 

PLANNING
  • Optimize oxygenation and ventilation
  • Decrease pain
  • Verbalize decrease in anxiety

IMPLEMENTATION
  • Apply face mask with 8L oxygen
  • Transfer to radiology for CT
  • Elevate head of bed
  • Administer medications as prescribed
  • Explain condition
  • Education on hydration, physical activity
  • Review symptoms of VTE
  • Review bleeding precautions 

EVALUATION
  • Respiratory rate: 22
  • Crackles
  • Heart rate: 90
  • Telemetry: normal sinus rhythm
  • Blood pressure: 110/80
  • Temperature: 98.0 F (36.6 C)
  • Pain: 4/10
  • Oxygen saturation: 95% 8L simple mask
  • Verbalizes education
  • Reports less anxiety

Transcript

Watch video only

Renata Gutierrez is a 34-year-old woman who came to the Emergency Department, or ED, with her partner, because of shortness of breath, chest pain, and coughing up blood-tinged sputum. The triage nurse informs you that Ms. Gutierrez delivered a healthy full-term baby by cesarean section one week ago. She has no other significant past medical history.

Venous thromboembolism, or VTE, refers to a clot that starts in a vein.

Specifically, a pulmonary embolism, or PE, occurs when an embolus, which is a small mass that could be a blood clot, fat, or even an air bubble, becomes lodged in the pulmonary artery and obstructs the pulmonary circulation. Most often the embolus is a blood clot associated with deep vein thrombosis, or DVT, which is when a clot forms in a large vein, usually in the leg or pelvis. The clot can break off and travel up the inferior vena cava to the right atrium, into the right ventricle, and finally into the pulmonary artery. This causes decreased blood flow to the lung tissue and impaired oxygenation.

Factors that increase the risk of a pulmonary embolism are summarized in Virchow triad, which include slowed blood flow, or venous stasis, hypercoagulation, meaning the blood is more likely to form clots, and damage to the endothelial lining of a blood vessel. Venous stasis can occur because of prolonged immobility like during a severe illness or after surgery, when an enlarged uterus compresses the nearby veins during pregnancy, or due to long-haul travel. Hypercoagulability can be caused by clotting disorders, use of oral contraceptives, smoking, and it occurs normally during pregnancy. And lastly, damage to the endothelial cell lining of a blood vessel can be the result of trauma or surgery.

Signs and symptoms of a pulmonary embolism depend on the size and location of pulmonary artery blockage. Even a small blockage impairs blood from getting into the lungs to pick up oxygen. Impaired oxygenation may cause a sudden onset of dyspnea, cough, tachypnea and chest pain that is described as pleuritic, meaning a sharp pain felt when inhaling and exhaling.

The patient may become disoriented and anxious from the hypoxemia, or they may report a feeling of apprehension and impending doom. As inflammation sets in, fluid buildup causes crackles which can be heard upon auscultation. Further deprivation of oxygen from the lung tissue leads to infarction of the lung tissue, which may result in hemoptysis. Complications from a PE can include pulmonary hypertension, right ventricular failure, shock and sudden death.

Diagnostics used to identify a PE include computed tomography pulmonary angiogram, or CTPA, where a dye is injected into the blood vessels to locate the blockage. A ventilation-perfusion scan, or V/Q scan, also called lung scintigraphy or ventilation-perfusion scintigraphy, can reveal areas of the lung that are ventilated, but not perfused, called a V/Q mismatch. Lab tests include a D-dimer test to detect fibrin breakdown products, which are usually present when there’s a blood clot.

Small clots may resolve on their own, however, large clots usually need treatment with fibrinolytic medications like tissue plasminogen activator, or tPA, to help break down the clot, and anticoagulants, like low molecular weight heparin to decrease blood coagulation. A

pulmonary embolectomy can also be done, either surgically or percutaneously, to remove the clot. For those at risk of developing further blood clots, anticoagulant medications may be given long term, or an inferior vena cava filter, or IVC filter, can be surgically placed into the inferior vena cava to prevent blood clots from entering the pulmonary artery and lungs. Keep in mind that the treatment course and medications may be influenced by factors such as whether the patient is pregnant or breastfeeding.

So, after you greet Ms. Gutierrez and introduce yourself as her nurse, you wash your hands, confirm her identity, and begin your assessment by asking how she’s doing. She replies she’s feeling short of breath, and it hurts every time she breathes. She goes on to tell you she has never experienced anything like this before and is very anxious. You notice that she has trouble getting the words out between breaths. After attaching a telemetry monitor, you observe sinus tachycardia with a heart rate of 110. Her respiratory rate is 30 per minute and shallow, she has a productive cough with blood-tinged sputum, and crackles are auscultated bilaterally. Her blood pressure is 95/72 mmHg, oral temperature 98.6° F, or 37°C, pain 6/10, and SpO2: 90% on room air.

Key Takeaways

Venous thromboembolism (VTE) is a condition where blood clots form in the veins, typically in the legs or pelvis, and can travel to the lungs, causing a pulmonary embolism (PE).

There are three main factors that lead to abnormal formation of clots, which are known as the Virchow's triad. They include venous stasis; a state of hypercoagulation; and damage to the endothelial cell lining. Venous stasis is said when blood doesn't flow appropriately in the veins due to prolonged periods of physical inactivity. Endothelial injury can occur when there is an injury or trauma to a blood vessel such as in trauma or surgery; and finally, hypercoagulable states can be seen in certain conditions like cancer and pregnancy.

Symptoms of VTE can include pain, swelling, warmth, and redness in the affected area, as well as shortness of breath, chest pain, and coughing up blood in the case of PE. The treatment involves thrombolytics to help break down the clot, or a thrombectomy, which is an intervention that aims to surgically remove the clot. Long-term treatment to prevent future thrombi from forming can include staying physically active, wearing compression stockings, and anticoagulant medications like warfarin or heparin.

Sources

  1. "Inflammation, Infection and Venous Thromboembolism. 128(12):2017-2036. " Circ Res. (2021)
  2. "Management of venous thromboembolism in pregnancy. 211:106-113. " Thromb Res (2022)
  3. "Long-term treatment of venous thromboembolism. 135(5):317-325. " Blood (2020)
  4. "Harrison’s Principles of Internal Medicine. 21st edition. ISBN: 978-1-264-26850-4 " McGraw Hill / Medical (2022)
  5. "Epidemiology and prevention of venous thromboembolism. 20(4):248-262. " Nat Rev Cardiol. (2023)
  6. "American Society of Hematology 2021 guidelines for management of venous thromboembolism: prevention and treatment in patients with cancer. 5(4):927-974. " Blood Advances. (2021)
  7. "Robbins & Kumar Basic Pathology. 11th edition. ISBN: 978-0-323-79018-5 " Elsevier (2022.)